General Information of Drug (ID: DML48NA)

Drug Name
PMID25435285-Compound-50
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 496.4
Logarithm of the Partition Coefficient (xlogp) 2.7
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 12
Chemical Identifiers
Formula
C20H13F5N6O2S
IUPAC Name
3-[1-[4-(difluoromethyl)-6-[6-(trifluoromethyl)pyridin-3-yl]pyrimidin-2-yl]imidazol-4-yl]benzenesulfonamide
Canonical SMILES
C1=CC(=CC(=C1)S(=O)(=O)N)C2=CN(C=N2)C3=NC(=CC(=N3)C(F)F)C4=CN=C(C=C4)C(F)(F)F
InChI
InChI=1S/C20H13F5N6O2S/c21-18(22)15-7-14(12-4-5-17(27-8-12)20(23,24)25)29-19(30-15)31-9-16(28-10-31)11-2-1-3-13(6-11)34(26,32)33/h1-10,18H,(H2,26,32,33)
InChIKey
OGTCWWKKFTYEFV-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
67393308
TTD ID
D0YZ7D

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Metabotropic glutamate receptor 2 (mGluR2) TTXJ47W GRM2_HUMAN Antagonist [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Metabotropic glutamate receptor 2 (mGluR2) DTT GRM2 1.09E-01 -0.11 -0.2
Metabotropic glutamate receptor 2 (mGluR2) DTT GRM2 3.19E-01 -0.06 -0.34
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 - present).Expert Opin Ther Pat. 2015 Jan;25(1):69-90.